Kewaunee Scientific Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics

Nov 10 2025 03:42 PM IST
share
Share Via
Kewaunee Scientific Corp., a microcap in the Pharmaceuticals & Biotechnology sector, has recently adjusted its valuation. The company exhibits strong financial metrics, including a P/E ratio of 6 and a return on equity of 29.30%, indicating effective management and a competitive position within its industry.
Kewaunee Scientific Corp., a microcap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a valuation adjustment. The company's financial metrics reflect a P/E ratio of 6 and a price-to-book value of 1.85, indicating a distinct market positioning. Additionally, Kewaunee's EV to EBIT stands at 9.67, while its EV to EBITDA is recorded at 7.61, showcasing its operational efficiency.

The company has demonstrated a solid return on capital employed (ROCE) of 16.14% and a robust return on equity (ROE) of 29.30%, highlighting its profitability and effective management of shareholder equity.

In comparison to its peers, Kewaunee Scientific Corp. stands out with a more favorable valuation profile. While some competitors are classified as risky, Kewaunee's metrics suggest a stronger financial foundation. Notably, Pro-Dex, Inc. is recognized as very attractive, but Kewaunee's valuation remains competitive within the industry landscape.

Overall, the recent evaluation revision reflects the company's solid financial health amidst a challenging market environment.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Kewaunee Scientific Corp. overvalued or undervalued?
Sep 20 2025 05:39 PM IST
share
Share Via
Is Kewaunee Scientific Corp. overvalued or undervalued?
Jun 25 2025 08:16 AM IST
share
Share Via
What does Kewaunee Scientific Corp. do?
Jun 22 2025 06:04 PM IST
share
Share Via